Sharechat Logo

Horizon Energy cuts guidance on regulation, acquisition; Mainzeal losses still to come

Monday 11th February 2013

Text too small?

Eastern Bay of Plenty electricity lines company Horizon Energy has sliced its forecast earnings by a fifth on the cost of regulation and last year's Aquaheat acquisition, and signalled there may be more to come due to its exposure to the collapse of Mainzeal Property and Construction.

The Whakatane-based company expects to post net profit of $3.4 million in the year ending March 31, down from a previous forecast of $4.3 million, Horizon said in a statement. That's down from earnings of $6.4 million a year earlier. The downgrade doesn't include any loss arising from the Mainzeal receivership, which it said last week would hit its bottom line.

Chairman Rob Tait said the reduction was due to increased transmission costs, a provision made for a Commerce Commission required price decision, expected losses from its Aquaheat subsidiary and acquisition costs relating to the purchase.

Horizon also warned any mark to market changes in the value of its interest rate swap portfolio between this month and the end of the financial year may impact on the forecast.

The infrequently traded shares were unchanged at $3.40 on Friday, and have gained 3 percent this year.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors